EP3466955
Aðferð við að framleiða oxasóló[4,5-b]pýridín og þíasóló[4,5-b]pýridín afleiður sem IRAK4 hemla til að meðhöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.1.2015EP published:
16.12.2020EP application number:
18190333.7
EP translation filed:
21.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
11.1.2035Expiry date:
11.1.2027Next due date:
31.1.2027
Title:
METHOD OF PREPARING OXAZOLO[4,5-B]PYRIDINE AND THIAZOLO[4,5-B]PYRIDINE DERIVATIVES AS IRAK4 INHIBITORS FOR TREATING CANCER
Timeline
Today
12.1.2015EP application
16.12.2020EP Publication
21.1.2021Translation submitted
15.2.2021Registration published
11.1.2027Expires
Owner
Name:
Aurigene Oncology LimitedAddress:
39/49(P)KIADB Industrial Area, Electronic City Phase-II, Bangalore, Karnataka 560100, IN
Inventor
Name:
GUMMADI, Venkateshwar, RaoAddress:
Bangalore 560100, IN
Name:
SAMAJDAR, SusantaAddress:
Bangalore 560078, IN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
158CH2014Date:
13.1.2014Country:
IN
Number:
3000CH2014Date:
20.6.2014Country:
IN
Classification
Categories:
C07D 498/04, C07D 513/04, C07D 519/00, A61K 31/437, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 19.1.2021
Expires: 11.1.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.12.2021
Expires: 11.1.2023
Payer: Patice ehf.
Number: 9
Paid: 30.12.2022
Expires: 11.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.12.2023
Expires: 11.1.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.12.2024
Expires: 11.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.1.2026
Expires: 11.1.2027
Payer: Árnason Faktor ehf.